Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235079
Status:
COMPLETED
Last Update Posted:
2013-08-07
First Post:
2005-10-06
Brief Title:
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment
Sponsor:
Azienda Sanitaria Locale 3 Torino
Organization:
Azienda Sanitaria Locale 3 Torino
Study Overview
Official Title:
Treatment and Prevention of Pericarditis With Colchicine A Multicenter Double Blind Randomized Trial The CORP 2 Trial COlchicine for Recurrent Pericarditis
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CORP 2
Brief Summary:
The purpose of the study is to determine whether colchicine is safe and effective in treatment and prevention of recurrent pericarditis after failure of conventional treatment
Detailed Description:
Colchicine is safe and effective in the management of recurrent pericarditis after failure of conventional treatment Preliminary data observational non-randomized studies without a control group have shown that the drug may be effective in treatment of the second and subsequent recurrence and the prevention of further recurrences
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUDRACT number 2005-001570-28 | None | None | None |